Aspen Pharmacare Holdings Limited

JSE:APN Stock Report

Market Cap: R103.5b

Aspen Pharmacare Holdings Management

Management criteria checks 4/4

Aspen Pharmacare Holdings' CEO is Stephen Saad, appointed in Jan 2000, has a tenure of 24.33 years. total yearly compensation is ZAR24.15M, comprised of 38% salary and 62% bonuses, including company stock and options. directly owns 12.84% of the company’s shares, worth ZAR13.28B. The average tenure of the management team and the board of directors is 7.2 years and 5.1 years respectively.

Key information

Stephen Saad

Chief executive officer

R24.1m

Total compensation

CEO salary percentage38.0%
CEO tenure24.3yrs
CEO ownership12.8%
Management average tenure7.2yrs
Board average tenure5.1yrs

Recent management updates

Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Dec 01
Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation

Dec 02
Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation

Recent updates

We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt

May 08
We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt

Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable

Mar 05
Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable

Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Dec 22
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Dec 01
Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment

Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

Mar 31
Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet

With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case

Jan 11
With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case

These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well

Oct 22
These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well

We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease

Oct 06
We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease

Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's

Sep 21
Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's

Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially

Sep 08
Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially

Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26

Sep 07
Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26

Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today

Jun 15
Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today

Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly

Apr 02
Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting

Mar 16
With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting

An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued

Mar 02
An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued

Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?

Dec 23
Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?

Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation

Dec 02
Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation

We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative

Oct 11
We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative

After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar

Sep 30
After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar

Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump

Sep 30
Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump

CEO Compensation Analysis

How has Stephen Saad's remuneration changed compared to Aspen Pharmacare Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

R5b

Sep 30 2023n/an/a

R5b

Jun 30 2023R24mR9m

R5b

Mar 31 2023n/an/a

R6b

Dec 31 2022n/an/a

R6b

Sep 30 2022n/an/a

R6b

Jun 30 2022R23mR9m

R6b

Mar 31 2022n/an/a

R6b

Dec 31 2021n/an/a

R6b

Sep 30 2021n/an/a

R5b

Jun 30 2021R24mR8m

R5b

Mar 31 2021n/an/a

R4b

Dec 31 2020n/an/a

R4b

Sep 30 2020n/an/a

R4b

Jun 30 2020R23mR8m

R3b

Mar 31 2020n/an/a

R3b

Dec 31 2019n/an/a

R870m

Sep 30 2019n/an/a

R1b

Jun 30 2019R14mR8m

R2b

Mar 31 2019n/an/a

R3b

Dec 31 2018n/an/a

R5b

Sep 30 2018n/an/a

R5b

Jun 30 2018R17mR7m

R6b

Mar 31 2018n/an/a

R6b

Dec 31 2017n/an/a

R6b

Sep 30 2017n/an/a

R5b

Jun 30 2017R17mR7m

R5b

Compensation vs Market: Stephen's total compensation ($USD1.32M) is below average for companies of similar size in the ZA market ($USD2.18M).

Compensation vs Earnings: Stephen's compensation has been consistent with company performance over the past year.

CEO

Stephen Saad (59 yo)

24.3yrs

Tenure

R24,149,000

Compensation

Mr. Stephen Bradley Saad, BCom, CA(SA), serves as the Group Chief Executive Officer of Aspen Pharmacare Canada Inc. Mr. Stephen has been the Group Chief Executive Officer of Aspen Pharmacare Holdings Limit...

Leadership Team

NamePositionTenureCompensationOwnership
Stephen Saad
Group CEO & Executive Director24.3yrsR24.15m12.84%
ZAR 13.3b
Sean Capazorio
Group CFO & Executive Director25.3yrsR15.55mno data
Lorraine Hill
Group Chief Operations Officer & Responsible Pharmacist10.5yrsR16.59mno data
Michael Attridge
Group Chief Advisor2.3yrsR12.62m4.31%
ZAR 4.5b
Reginald Haman
Group Chief Corporate Services Officer & Executive Directorless than a yearR14.21mno data
Zizipho Mmango
Group Chief Strategic Development Officer4yrsR13.87mno data
Sibongakonke Nkosi
Investor Relations Managerno datano datano data
Trevor Ziman
Regional Chief Executive Officer of Asia Pacific10.3yrsno datano data
Samer Kassem
Chief Executive Officer of Aspen Global Incorporated7.2yrsno datano data
Raeesa Khan
Group Company Secretaryless than a yearno datano data
Luresha Chetty
Corporate Affairs & Investor Relations Executiveno datano datano data

7.2yrs

Average Tenure

53.5yo

Average Age

Experienced Management: APN's management team is seasoned and experienced (7.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Stephen Saad
Group CEO & Executive Director25.3yrsR24.15m12.84%
ZAR 13.3b
Sean Capazorio
Group CFO & Executive Director2.3yrsR15.55mno data
Reginald Haman
Group Chief Corporate Services Officer & Executive Directorless than a yearR14.21mno data
Ben Kruger
Lead Independent Non-Executive Director5.1yrsR932.00kno data
Christopher Mortimer
Non-Executive Director25.3yrsR465.00kno data
Kuseni Dlamini
Independent Non-Executive Chairman12.1yrsR1.41mno data
Yvonne Muthien
Independent Non-Executive Director2.4yrsR548.00kno data
David Redfern
Non-Executive Director9.3yrsR364.00kno data
Linda de Beer
Independent Non-Executive Director5.8yrsR958.00kno data
Neo Dongwana
Independent Non-Executive Directorless than a yearno datano data
Themba Mkhwanazi
Independent Non-Executive Director5.1yrsR448.00kno data

5.1yrs

Average Tenure

56yo

Average Age

Experienced Board: APN's board of directors are considered experienced (5.1 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.